Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Solvexis Consult is seeking an experienced Risk Coordinator to support a pharmaceutical project during turnover, commissioning, qualification and validation (CQV). You will coordinate RAMS, assess low/medium risks, and assist with high‑risk activities on site.
The role emphasizes structured risk management, collaboration with discipline leads, and ensuring safe commissioning and regulatory compliance throughout CQV.
Full time | Solvexis Consult | Denmark
Posted On 17-09-2026
Job Opening Status In-progress
Construction
Work Experience 4-5 years
City Hillerød
State/Province Sjælland
030353
Risk Coordinator – Pharmaceutical Project
Working hours: 40 hours per week
Start: As soon as possible
Assignment duration: Until 28 February 2027
About the position
Solvexis Consult is looking for an experienced Risk Coordinator to support a pharmaceutical project during turnover, commissioning, qualification and validation (CQV).
You will coordinate the daily preparation and review of risk assessments and method statements (RAMS), conduct assessments for low- and medium-risk activities, and support the assessment of high-risk work.
The role combines structured risk management with an active presence on site. Working closely with workstream leads, technical disciplines and Permit-to-Work and LOTO Coordinators, you will help ensure that activities are properly assessed, planned and executed safely.
Responsibilities
Your primary responsibilities will include:
Qualifications and experience
We expect that you have:
What we offer
At Solvexis, you will be supported throughout your assignment through structured onboarding, administrative support, documentation assistance and regular follow-up.
You will join a pharmaceutical project where your contribution directly supports safe working practices and coordination across technical disciplines.
Employment terms will be agreed based on your qualifications, experience and the conditions of the assignment.